ADAG Adagene Inc: Earnings per share for the last twelve months
High barriers to entry, driven by proprietary AI algorithms and the complexity of bioinformatics, support Adagene (ADAG) valuations. The company's 12-month specific profit level demonstrates the impact of these drivers, where the value -0.38 indicates the parameter's status. The business relies on B2B antibody design for oncology, while exclusive rights to SAFEbody technology and FDA oversight provide robust protection for its intellectual capital.
Analytical breakdowns and data insights for company Adagene Inc (ADAG)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
- earnings and valuation multiples indicators:
ADAG - Annual Net Income|Projected Future Earnings Adagene|ADAG - Market Cap to Earnings|Future Price to Earnings Adagene Corp|ADAG - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Adagene Inc.|ADAG - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Adagene|ADAG - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth adagene.com|ADAG - Earnings per share growth this year|Earnings growth forecast for next year Adagene
Analysis of all company metrics:adagene.com (ADAG)
Adagene is optimizing the cross-border delivery of biocomponents through its laboratory network to protect margins. This metric calculates the net profit allocated per share over the last 12 months, excluding the impact of issuance volume. It allows investors to assess the real efficiency of the business regardless of the capital structure. Growth in this indicator signals the capitalization of operational successes. By analyzing the rolling per-share income metric, one can determine a sustainable entry point.
Direct competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BCRX - Net earnings per share (EPS TTM)|VERA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months DNTH|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) AbCellera Biologics Inc|Net earnings per share (EPS TTM) TRML|Precigen Corp (PGEN) - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|nektar.com (NKTR) - Net earnings per one share for the last twelve months|UPB - Earnings per share for the last twelve months|ZBIO (Zenas Bio) - Earnings per share for the last 12 months|IMNM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Gossamer Bio Corp. (GOSS)|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) septerna.com|Net earnings per share (EPS TTM) PVLA|Savara Inc - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|Net earnings per share (EPS TTM) AnaptysBio Inc. ANAB|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year engene.com (ENGN)|RAPT Therapeutics, Inc. (RAPT) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months JBIO (Aerovate Therapeutics)|ACRS (Aclaris) - Net earnings per share (EPS TTM)|KYTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TLSA|Net earnings per share (EPS TTM) cabalettabio.com (CABA)|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|Earnings per share for the trailing year THTX|AVTX - Earnings per share for the last twelve months|Eledon Pharmaceuticals, Inc (ELDN) - Net earnings per share for the last 12 months|AGEN: Net earnings per share (EPS TTM)|climbbio.com (CLYM) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ZURA|ATYR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters shattucklabs.com|Earnings per share for the last twelve months Equillium EQ|CNTB - Net earnings per share for the last 12 months|IMUX - Earnings per share for the last twelve months|Atara Biotherapeutics (ATRA) - Net earnings per share for the last 12 months|IFRX (inflarx.de) - Net earnings per share for the last 12 months|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Adicet Bio Inc.|Earnings per share for the last 12 months CELU (Celularity Corp)|Net earnings per share (EPS TTM) INMB|BRNS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share (EPS TTM) SAB Biotherapeutics Inc SABS|Akari Therapeutics - Net earnings per share (EPS TTM)|ENLV (Enlivex Therapeutics) - Earnings per share for the last 12 months|QTTB: Net earnings per share (EPS TTM)|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|EDSA (Edesa) - Net earnings per share (EPS TTM)|IBIO - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) CARM|XTLB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB: Earnings per share for the last 12 months|Aptevo - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AIM ImmunoTech, Inc.|ADTX: Net earnings per share (EPS TTM)|gribio.com (GRI) - Net earnings per share (EPS TTM)|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months HIND (Vyome Holdings Inc.)|Net earnings per share (EPS TTM) REVB|Net earnings per share (EPS TTM) Indaptus Corp (INDP)|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|Net earnings per share for the trailing year CalciMedica Inc|AFMD - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ALLK|HOOK: Net earnings per share (EPS TTM)|IGM Biosciences - Earnings per share for the trailing year|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oceanbiomedical.com|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Earnings per share for the trailing year
